Author: Brüggemann, Renée A.G.; Spaetgens, Bart; Gietema, Hester A.; Brouns, Steffie H.A.; Stassen, Patricia M.; Magdelijns, Fabienne J.; Rennenberg, Roger J.; Henry, Ronald M.A.; Mulder, Mark M.G.; van Bussel, Bas C.T.; Schnabel, Ronny M.; van der Horst, Iwan C.C.; Wildberger, Joachim E.; Stehouwer, Coen D.A.; ten Cate, Hugo
Title: The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison Cord-id: t0s3a2k2 Document date: 2020_10_15
ID: t0s3a2k2
Snippet: BACKGROUND: The risk of pulmonary embolism (PE) in patients with Coronavirus Disease 2019 (COVID-19) is recognized. The prevalence of PE in patients with respiratory deterioration at the Emergency Department (ED), the regular ward, and the Intensive Care Unit (ICU) are not well-established. OBJECTIVES: We aimed to investigate how often PE was present in individuals with COVID-19 and respiratory deterioration in different settings, and whether or not disease severity as measured by CT-severity sc
Document: BACKGROUND: The risk of pulmonary embolism (PE) in patients with Coronavirus Disease 2019 (COVID-19) is recognized. The prevalence of PE in patients with respiratory deterioration at the Emergency Department (ED), the regular ward, and the Intensive Care Unit (ICU) are not well-established. OBJECTIVES: We aimed to investigate how often PE was present in individuals with COVID-19 and respiratory deterioration in different settings, and whether or not disease severity as measured by CT-severity score (CTSS) was related to the occurrence of PE. PATIENTS/METHODS: Between April 6th and May 3rd, we enrolled 60 consecutive adult patients with confirmed COVID-19 from the ED, regular ward and ICU who met the pre-specified criteria for respiratory deterioration. RESULTS: A total of 24 (24/60: 40% (95% CI: 28–54%)) patients were diagnosed with PE, of whom 6 were in the ED (6/23: 26% (95% CI: 10–46%)), 8 in the regular ward (8/24: 33% (95% CI: 16–55%)), and 10 in the ICU (10/13: 77% (95% CI: 46–95%)). CTSS (per unit) was not associated with the occurrence of PE (age and sex-adjusted OR 1.06 (95%CI 0.98–1.15)). CONCLUSION: The number of PE diagnosis among patients with COVID-19 and respiratory deterioration was high; 26% in the ED, 33% in the regular ward and 77% in the ICU respectively. In our cohort CTSS was not associated with the occurrence of PE. Based on the high number of patients diagnosed with PE among those scanned we recommend a low threshold for performing computed tomography angiography in patients with COVID-19 and respiratory deterioration.
Search related documents:
Co phrase search for related documents- active malignancy and logistic regression: 1, 2, 3, 4
- active malignancy and logistic regression analysis: 1
- acute ards respiratory distress syndrome and admission therapy antiplatelet: 1
- acute ards respiratory distress syndrome and local hospital: 1, 2, 3, 4
- acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute ards respiratory distress syndrome and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and low threshold: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and lung abnormality: 1, 2
- acute ards respiratory distress syndrome and lung window: 1, 2
- acute ards respiratory distress syndrome development and logistic regression: 1, 2, 3
- acute ards respiratory distress syndrome development and logistic regression analysis: 1
- acute ards respiratory distress syndrome development and low molecular weight heparin: 1
- acute ards respiratory distress syndrome development and low threshold: 1
- admission therapy antiplatelet and logistic regression: 1
- admission therapy antiplatelet and low molecular weight heparin: 1
- local hospital and logistic regression: 1, 2, 3, 4, 5, 6
- local hospital and logistic regression analysis: 1
- local hospital and lung abnormality: 1
Co phrase search for related documents, hyperlinks ordered by date